Reneo Pharmaceuticals, Inc.

NASDAQ:RPHM

18.2 (USD) • At close October 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12001 Q3
Operating Activities:
Net Income -5.361-8.426-23.554-19.196-19.531-15.107-13.6-13.007-12.312-13.036-10.607-12.735-9.216-7.212-6.253-5.094-3.687-4.4310
Depreciation & Amortization 0.0120.0160.0440.0430.0420.0410.0250.0220.0220.0190.0170.0130.010.010.010.0090.0090.0090
Deferred Income Tax 002.779-1.538-1.241000007.7960.080000000
Stock Based Compensation 0.9891.0781.3191.4291.2071.1571.2170.991.0061.1071.4211.1450.8540.4710.1290.0840.0880.0920
Change In Working Capital -1.783-12.8594.080.1892.7365.213-2.6871.237-0.7453.154-1.1011.904-1.745-1.8580.701-0.7390.654-0.1020
Accounts Receivables 0000000000000000000
Change In Inventory 0000000000000000000
Change In Accounts Payables -1.466-15.3634.611-0.1833.2923.398-2.321.58701.251-0.0362.98-0.237-0.9271.466-0.9140.8980.0360
Other Working Capital -0.3172.50410.5870.372-0.556-3.398-0.367-0.35-1.221.903-1.065-1.076-1.508-0.931-0.7650.175-0.244-0.1380
Other Non Cash Items 1.81515.65-0.2350.3060.673-0.352-0.568-0.0360.098-0.243-7.547-0.0790.3960.4910.002-0.001-0.001-0.0150
Operating Cash Flow -6.807-21.014-19.753-18.767-16.114-9.048-15.613-10.794-11.956-8.999-10.021-9.672-9.701-8.589-5.411-5.741-2.937-4.4470
Investing Activities:
Investments In Property Plant And Equipment -0.0020-0.025-0.019-0.005-0.172-0.25-0.028-0.024-0.044-0.09-0.077-0.006-0.025-0.016-0.0070-0.0010
Acquisitions Net 00-0.0500.069-0.0190.0270.04500-58.39500000000
Purchases Of Investments -22.507-45.243-41.199-57.731-104.006-28.321-34.267-51.4070.107-16.0290.015-4.432-26.989000000
Sales Maturities Of Investments 4559817935477.66921.58.22800001.215.20
Other Investing Activites 22.49313.7570.040.021-0.0690.019-0.027-0.0459.1075.47158.395-4.432-26.989001.215.20
Investing Cash Flow 22.49113.75739.77621.25-69.01118.507-26.917-45.4359.0835.4278.153-4.509-26.995-0.025-0.0161.19315.1990
Financing Activities:
Debt Repayment 0000000000000000000
Common Stock Issued -0.089000.17363.5291.0090.1320.146-0.0060.006-0.0290.00285.84346.22200000
Common Stock Repurchased 00-4.4030000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities -0.08900.2750.1730.28200.3250.0970.04300.1190.2285.82446.22247.1950.05100.0260
Financing Cash Flow -0.0890-4.1280.17363.8111.0090.3250.0970.0430.0060.1190.22285.84346.22247.1950.05100.0260
Other Information:
Effect Of Forex Changes On Cash 0000000000-1.93700000000
Net Change In Cash 15.595-7.25715.8952.656-21.31410.468-42.205-56.132-2.83-3.566-1.749-13.95949.14737.60841.768-4.497-1.9370.7780
Cash At End Of Period 35.9720.37527.63211.7379.08130.39519.92762.132118.264121.094124.66126.409140.36891.22153.61311.84516.34218.2790